Life ScienceCompany
LYSTEDA Ownership
Who owns LYSTEDA?
LYSTEDA is owned by Amring Pharmaceuticals. It was acquired on December 2, 2020.
LYSTEDA Business Overview
Where is LYSTEDA headquartered?
LYSTEDA is headquartered in Switzerland.
What sector is LYSTEDA in?
LYSTEDA is a life science company.
Life Science M&A Summary in 2020
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.
Join Mergr to view all 290 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 267 by strategics.